Ajay Sharma S

2020202120222023202420251 9 33 41 53 15

Public access

2 articles

available

not available

Based on funding mandates

Priyankar Paira, PhD, MRSCAssociate Professor , VITVerified email at vit.ac.in
Sudhindra PeteM.Sc. Organic Chemistry, Vellore Institute of TechnologyVerified email at vitstudent.ac.in
Nilmadhab RoyVellore Institute of Technology (VIT), Tamilnadu, Vellore-632014Verified email at vit.ac.in
Binoy KarAssociate Member of Royal Society of Chemistry (AMRSC), PhD Research Scholar of Chemistry, VelloreVerified email at vit.ac.in
PRITHVI MOHARANADoctoral Researcher (BBSRC Fellow), University of ManchesterVerified email at postgrad.manchester.ac.uk

Ajay Sharma S

Verified email at uq.net.au


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Advances in novel iridium (III) based complexes for anticancer applications: A review A Sharma, P Sudhindra, N Roy, P Paira Inorganica Chimica Acta 513, 119925, 2020	59	2020
Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review P Sudhindra, SA Sharma, N Roy, P Moharana, P Paira Polyhedron 192, 114827, 2020	37	2020
Target-specific mononuclear and binuclear rhenium (i) tricarbonyl complexes as upcoming anticancer drugs A Sharma, N Vaibhavi, B Kar, U Das, P Paira RSC advances 12 (31), 20264-20295, 2022	31	2022
GSH-resistant and highly cytoselective ruthenium (II)-p-cymene-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol complexes as potential anticancer agents B Kar, U Das, S De, S Pete, A Sharma, N Roy, AK SK, D Panda, P Paira Dalton Transactions 50 (30), 10369-10373, 2021	20	2021
Iridium (III)–Cp*-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem … B Kar, S Shanavas, AH Nagendra, U Das, N Roy, S Pete, A Sharma, S De, ... Dalton Transactions 51 (14), 5494-5514, 2022	7	2022

The system can't perform the operation now. Try again later.

Articles 1–5

Citations per year